OpiSafe Company
Mission
RxAssurance’s Mission is to prevent, monitor, detect and treat drug misuse with our healthcare technology Platform as a Service [PaaS].
Products
OpiSafe
OpiSafe is a clinical decision support dashboard used by over 6,000 prescribers in multiple states that integrates into all major EHR systems, providing comprehensive, guideline adherent opioid prescribing and patient risk monitoring to assure appropriate opioid use, improved health outcomes and lower total cost of care.
The state of Colorado’s Medicaid Program recently awarded a five [5] year contract to RxAssurance as the exclusive monitoring software and Hub for Providers to deliver comprehensive, guideline adherent opioid prescribing and patient risk profile monitoring (controlled substances monitoring – including opioids, benzodiazepines, and stimulants), and to assure appropriate opioid use and improve health outcomes for Health First Colorado Members.
OpiRescue
OpiRescue is our Smartphone app product that gives laypeople a tool for recognizing and responding to an overdose and gives agencies and organizations access to powerful deidentified data and outreach tools to better serve their clients and communities. The app is free and available of both Apple and Android phones.
With over 40,000 users nationwide and in every state, our users have reported ed over 3,000 lives saved from overdose. The states of Colorado, Michigan, Nebraska and Delaware have licensed our cloud based OpiRescue data analytics Hub for statewide implementation in response to growing overdoses, providing their state agencies and harm reduction organizations powerful data and outreach tools to better serve their clients and communities.
Hub
Our cloud-based data analytics hub collects activity for all user, Patient and Provider encounters with our PAAS products. For large upstream stakeholders, we license aggregated, de-identified data analytics for population-based trends to guide and confirm behavior changes that result in desired economic and clinical outcomes.
With multiple patents pending, RxAssurance was recently awarded US11640857B2 patent for its "Techniques for providing referrals for opioid use disorder treatment using blockchain'.
